Usa Germany covid-19 information vaccine track Usa Germany

FDA grants fast track status to Pfizer, BioNTech’s Covid-19 vaccines

Reading now: 137
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Pfizer and BioNTech have received fast track designation from the US Food and Drug Administration (FDA) for two of their four potential Covid-19 vaccines.

The two potential vaccines, BNT162b1 and BNT162b2, are part of the companies’ BNT162 mRNA-based vaccine programme. The candidates are currently in ongoing Phase I / II clinical trials in the US and Germany.

FDA granted the fast track designation after reviewing preliminary results from Phase I / II studies and also data from animal immunogenicity studies.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA